All living cells are metabolically active.
They produce heat. We measure it.
Simplicity. Specificity. Sensitivity.
And Amazing Speed.
We are Masters of Biocalorimetry.

In a nutshell
Biocalorimetry
Biocalorimetry is amazing. It’s unbelievably versatile. It’s sensitive, specific and simple in terms of process. And it’s crazy fast. In short, it is revolutionising numerous industries and opening avenues of opportunity that have seemed impassable for years.
We are Masters of the Craft.
Get in touch and join us on this journey. Let’s investigate together how we can apply our expertise to further your pursuits. It’s going to be exciting.

Accelerating release times for cell & gene therapies
Rapid
sterility testing
Our biocalorimetry system has the capability to transform rapid sterility testing for advanced therapies. With its seamless, easy workflow, it delivers the fastest detection of living microorganisms. This enables release testing in three days or less. We help developers and clinical labs make significant savings in cost, cut vein-to-vein times and improve patient access.
Contact us to join the innovators shaping the future of rapid microbial detection.
Stay on top of your game
Knowledge
Hub
We absolutely love biocalorimetry, and are keen to spread the news! Here you can stay up to date with the latest findings in the industry – both ours and in the market. Go to the end of the page to subscribe to our newsletter so you don’t miss a thing and stay on top of your game.
Questions? Contact us here… We look forward to working with you.
Stay up-to-date
.jpg)
16 SEPTEMBER 2025
Symcel enters into R&D collaboration with Johnson & Johnson to advance rapid sterility testing in cell & gene therapies
.jpg)
16 - 18 Sep 2025
Cell & Gene Therapy International
Join us at Cell & Gene Therapy International 2025 in Boston.
.jpg)
10 JULY 2025
Symcel strengthens strategic position with new board member and senior leadership appointment
.jpg)
28 May 2025
New investment boosts Symcel’s development and rollout of rapid sterility testing solutions for advanced therapies

4th March 2025